Improvement of thrombocytopenia after treatment for Helicobacter pylori in a patient with immunologic thrombocytopenic purpura

AUTOR(ES)

Rocha, Aline Maia, Botelho, Luís Fábio Barbosa, Rocha, David Maia

FONTE

Rev. Bras. Hematol. Hemoter.

DATA DE PUBLICAÇÃO

2014-04

RESUMO

Immune thrombocytopenic purpura is the most common autoimmune hematologic disease, affecting individuals of different ages. Recently, the bacterium Helicobacter pylori entered the list of causes of immune thrombocytopenic purpura. Here we present the case of a 55-year-old female patient with low platelet counts initially attributed to chronic vaginal bleeding. As corticosteroid therapy was ineffective she was treated for H. pylori infection. Within four weeks the patient had a platelet count of 87.17 ×109/L accompanied by clinical improvement of the symptoms.

Documentos Relacionados

• Helicobacter pylori and idiopathic thrombocytopenic purpura
• Platelet count response to Helicobacter pylori eradication for idiopathic thrombocytopenic purpura in northeastern Brazil
• Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab
• Invasive aspergillosis in a patient with idiopathic thrombocytopenic purpura without underlying lung disease.
• Thrombotic thrombocytopenic purpura presenting as recurrent thrombocytopenia in a young female — A case report